Heron Therapeutics, Inc. Blog | Talkmarkets | Page 1
No data available
No data available
Latest Posts
1 to 16 of 16 Posts
Wall Street's Top Stories At Midday, May 1st
Article By: The Fly Wednesday, May 1, 2019 1:35 PM EDT
Stocks rise after Apple earnings beat as investors await the Fed.
In this article: CVS, HD, NUS, PCRX, AAPL, GILD, GRMN, ENPH, HRTX, TWLO, NBRV
Read
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs
Article By: Benzinga Saturday, April 27, 2019 6:05 PM EDT
Biotech stocks staged a recovery this week after being in the red in the previous two weeks.
In this article: BTX, BOLD, REGN, BIIB, GWPH, ALDX, HRTX, IONS, ADAP, NBRV, BHVN, NVS, SNY, RHHBY, ABBV
Read
Wall Street's Top Stories For Monday, Dec 31
Article By: The Fly Monday, December 31, 2018 5:12 PM EDT
Though December has been a bad month for the market, stocks opened in positive territory on the prospects of progress in the trade negotiations between the U.S. and China. Plus company news updates on Amazon, Disney, Verizon, and more.
In this article: CWH, DIS, VZ, AMZN, HRTX, PTLA, APHA
Read
Biotech Stocks Emerge Unscathed And Ready To Go
Article By: Tarun Chandra, CFA Friday, May 18, 2018 8:41 PM EDT
The biotech stocks have been demonstrating strong resilience in the face of intense volatility since February and, remarkably, keeping pace with the broader indexes, considering the highly speculative and volatile nature of the group.
In this article: CVS, MRK, IBB, INCY, ESRX, XBI, ARNA, ECYT, IMMU, IRWD, DVAX, SUPN, SRPT, AGIO, QURE, HRTX, LOXO, ATRA, BGNE, ADAP, CRSP, CBIO, GTHX, MRTX
Read
5 Top Small-Caps To Track In Volatile Markets
Article By: TipRanks Sunday, March 25, 2018 1:31 PM EDT
The market is still in normal correction territory. However, some stocks may be better suited to volatility than others. And one of these groups is small cap stocks.
In this article: OFIX, HRTX, INST, SGH, XCRA
Read
10 Stocks To Soar In 2018
Article By: TipRanks Wednesday, December 13, 2017 2:18 PM EDT
The market is currently trading at record highs, boosted by the prospect of business-friendly tax reforms.
In this article: HRTX, LRCX, MSFT, AVGO, GBT
Read
Track These ‘Strong Buy’ Stocks Set To Leap Higher In Q4
Article By: TipRanks Friday, September 29, 2017 5:34 AM EDT
As we are entering the final quarter for 2017, I wanted to take a look ahead and see which top stocks are set to spike this quarter and beyond. Here are five stocks for your portfolio.
In this article: CBS, MU, AERI, HRTX, HUBS
Read
Five Biotech Stocks That Doubled In 2015
Article By: Zacks Investment Research Friday, January 8, 2016 5:10 AM EDT
It’s been a roller-coaster ride for the biotech sector in 2015, with several stocks seeing major highs and lows as the year progressed. The year will continue to see mergers and acquisitions and licensing and collaboration deals being signed.
In this article: LGND, EXEL, SRPT, HRTX, RVNC Also: AMGN, ABBV
Read
Heron's (HRTX) Post-Operative Pain Candidate Encourages
Article By: Zacks Investment Research Wednesday, September 23, 2015 8:07 PM EDT
Heron Therapeutics, Inc. announced positive, top-line data from a phase II study on HTX-011 for the management of post-operative pain in patients undergoing bunionectomy, developed using Heron’s proprietary Biochronomer drug delivery technology.
In this article: HRTX Also: VRX, REGN, GILD
Read
E Heron Therapeutics Announces Positive Phase 2 Results For Post-Operative Pain
Article By: Terry Chrisomalis Tuesday, September 22, 2015 8:03 PM EDT
Shares of Heron Therapeutics were up 22% in after hours trade after announcing positive phase 2 results for post-operative pain.
In this article: HRTX
Read
Heron Therapeutics - Chart Of The Day
Article By: Jim Van Meerten Friday, August 28, 2015 4:24 AM EDT
Heron Therapeutics Inc. is a specialty pharmaceutical company that develops products using its proprietary Biochronomer (TM) polymer-based drug delivery platform.
In this article: HRTX
Read
5 Stocks Leading XBI Biotech ETF Higher
Article By: Sweta Killa Friday, June 26, 2015 6:51 AM EDT
With an AUM of $2.3 billion and average daily volume of close to a million shares, XBI is extremely liquid and an easily traded fund. It provides equal weight exposure across 106 stocks by tracking the S&P Biotechnology Select Industry Index.
In this article: XBI, EGRX, HRTX, EXEL, RTRX, PRTA
Read
Wednesday Morning Pre-Market Insights: CTIC, BLUE, REGN, HRTX
Article By: TipRanks Wednesday, June 10, 2015 8:45 AM EDT
Wednesday Morning Pre-Market Insights: CTIC, BLUE, REGN, HRTX.
In this article: BLUE, CTIC, REGN, HRTX
Read
Wednesday’s Pre-Market Insights: GPRO, AMBA, AGEN, HRTX
Article By: TipRanks Wednesday, June 3, 2015 9:14 AM EDT
Wednesday’s Pre-Market Insights: GPRO, AMBA, AGEN, HRTX.
In this article: GPRO, AMBA, AGEN, HRTX
Read
Weekly Wrap-Up, Market Forecast, Sector Watch: SPX, Nasdaq - June 1, 2015
Article By: Andy Wang Monday, June 1, 2015 6:02 AM EDT
We traded really well last week although stocks slide again on Friday.
In this article: SPX, HRTX, UNP, TSLA, POST, AMZN, SLB, MYL, CAVM, XLNX, BRCM, NFLX, AVGO, ALK, TWC, NDX
Read
E Heron Therapeutics Reports Positive Phase 3 Results For Cancer Nausea Study
Article By: Terry Chrisomalis Thursday, May 28, 2015 6:04 PM EDT
Shares of Heron Therapeutics are up 40% in after hours trade after reporting positive phase 3 results from its MAGIC study in patients with chemotherapy induced nausea and vomiting
In this article: HRTX
Read
1 to 16 of 16 Posts